
Sign up to save your podcasts
Or
The US central bank has left interest rates unchanged this month but says they will be cut three times before the end of the year. We look into the details.
The world's most expensive drug will soon be available in the US at a price of $4.25m. We hear about the rare disease it treats and the high cost of developing medicine to battle it.
Sam Fenwick discusses these and more business stories with two guests on opposite sides of the world: Kristina Hooper, Chief Global Market Strategist at New York-based Invesco, and Yoko Ishikura, Professor Emeritus at Hitotsubashi University.
(Picture: US Federal Reserve Board Chairman Jerome Powell. Picture credit: SHAWN THEW/EPA-EFE/REX/Shutterstock.)
4.4
4141 ratings
The US central bank has left interest rates unchanged this month but says they will be cut three times before the end of the year. We look into the details.
The world's most expensive drug will soon be available in the US at a price of $4.25m. We hear about the rare disease it treats and the high cost of developing medicine to battle it.
Sam Fenwick discusses these and more business stories with two guests on opposite sides of the world: Kristina Hooper, Chief Global Market Strategist at New York-based Invesco, and Yoko Ishikura, Professor Emeritus at Hitotsubashi University.
(Picture: US Federal Reserve Board Chairman Jerome Powell. Picture credit: SHAWN THEW/EPA-EFE/REX/Shutterstock.)
5,426 Listeners
1,803 Listeners
7,657 Listeners
4,205 Listeners
524 Listeners
1,751 Listeners
1,074 Listeners
966 Listeners
284 Listeners
2,080 Listeners
1,042 Listeners
1,870 Listeners
365 Listeners
754 Listeners
196 Listeners
277 Listeners
224 Listeners
676 Listeners
700 Listeners
2,962 Listeners
24 Listeners
131 Listeners